A new original approach to the design of anticancer drugs based on energy-rich quadricyclanes


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Quadricyclane derivatives are shown for the first time to be promising for application as anticancer drugs. The efficiency of such cage compounds is mainly due to thermal action on cancer cells resulting from a C—C bond cleavage in quadricyclane on exposure to catalytic amounts of cisplatin Pt ions.

About the authors

U. M. Dzhemilev

Institute of Petroleum Chemistry and Catalysis, Russian Academy of Sciences

Email: tuktarovar@gmail.com
Russian Federation, 141 prosp. Oktyabrya, Ufa, Republic of Bashkortostan, 450075

A. R. Akhmetov

Institute of Petroleum Chemistry and Catalysis, Russian Academy of Sciences

Email: tuktarovar@gmail.com
Russian Federation, 141 prosp. Oktyabrya, Ufa, Republic of Bashkortostan, 450075

A. A. Khuzin

Institute of Petroleum Chemistry and Catalysis, Russian Academy of Sciences

Email: tuktarovar@gmail.com
Russian Federation, 141 prosp. Oktyabrya, Ufa, Republic of Bashkortostan, 450075

V. A. D’yakonov

Institute of Petroleum Chemistry and Catalysis, Russian Academy of Sciences

Email: tuktarovar@gmail.com
Russian Federation, 141 prosp. Oktyabrya, Ufa, Republic of Bashkortostan, 450075

L. U. Dzhemileva

Institute of Petroleum Chemistry and Catalysis, Russian Academy of Sciences

Email: tuktarovar@gmail.com
Russian Federation, 141 prosp. Oktyabrya, Ufa, Republic of Bashkortostan, 450075

M. M. Yunusbaeva

Institute of Petroleum Chemistry and Catalysis, Russian Academy of Sciences

Email: tuktarovar@gmail.com
Russian Federation, 141 prosp. Oktyabrya, Ufa, Republic of Bashkortostan, 450075

L. M. Khalilov

Institute of Petroleum Chemistry and Catalysis, Russian Academy of Sciences

Email: tuktarovar@gmail.com
Russian Federation, 141 prosp. Oktyabrya, Ufa, Republic of Bashkortostan, 450075

A. R. Tuktarov

Institute of Petroleum Chemistry and Catalysis, Russian Academy of Sciences

Author for correspondence.
Email: tuktarovar@gmail.com
Russian Federation, 141 prosp. Oktyabrya, Ufa, Republic of Bashkortostan, 450075

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2019 Springer Science+Business Media, LLC, part of Springer Nature